MAHBOOB ALAM to Time Factors
This is a "connection" page, showing publications MAHBOOB ALAM has written about Time Factors.
Connection Strength
0.530
-
Predictors of In-Hospital Mortality in Patients With End-Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Inpatient Sample Database Analysis. Cardiovasc Revasc Med. 2022 01; 34:63-68.
Score: 0.084
-
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol. 2017 Nov 01; 120(9):1514-1520.
Score: 0.066
-
Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy. Int J Cardiol. 2012 Apr 05; 156(1):101-4.
Score: 0.045
-
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
Score: 0.042
-
Personalizing Mechanical Circulatory Support for Cardiogenic Shock: A Review and Comparison of Current Devices. Catheter Cardiovasc Interv. 2025 Aug; 106(2):1446-1458.
Score: 0.028
-
Outcomes of Percutaneous Coronary Intervention in Nonagenarians in the United States. Catheter Cardiovasc Interv. 2025 Jul; 106(1):250-257.
Score: 0.028
-
Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction in the United States. Catheter Cardiovasc Interv. 2025 03; 105(4):745-751.
Score: 0.027
-
Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21-Year Retrospective Analysis of CDC-WONDER Database. Clin Cardiol. 2024 Dec; 47(12):e70058.
Score: 0.027
-
Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol. 2024 Jul 23; 31(9):1123-1131.
Score: 0.027
-
In-hospital complications after MitraClip in patients with heart failure and preserved versus reduced ejection fraction in the United States. Cardiovasc Revasc Med. 2024 May; 62:34-39.
Score: 0.025
-
Clinical Outcomes of Transcatheter Aortic Valve Replacement (TAVR) Vs. Surgical Aortic Valve Replacement (SAVR) in Patients With Durable Left Ventricular Assist Device (LVAD). Curr Probl Cardiol. 2022 Oct; 47(10):101313.
Score: 0.023
-
Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:108-110.
Score: 0.021
-
Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis. J Cardiovasc Pharmacol. 2021 01 01; 77(1):87-93.
Score: 0.021
-
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
Score: 0.020
-
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
Score: 0.018
-
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
Score: 0.018
-
Impact of prior antibiotic use in culture-negative endocarditis: review of 86 cases from southern Pakistan. Int J Infect Dis. 2009 Sep; 13(5):606-12.
Score: 0.009